United States


IRIX.OQ on NASDAQ Stock Exchange Global Market

4:00pm EDT
Change (% chg)

$-0.02 (-0.24%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Iridex Q3 preliminary revenues of approximately $9.6 to $9.7 mln
Tuesday, 11 Oct 2016 04:05pm EDT 

Iridex Corp : Iridex announces preliminary revenues for 2016 third quarter . Preliminary revenues of approximately $9.6 to $9.7 million for q3 ended october 1, 2016 . Iridex - while demand for Cyclo G6 laser platform for glaucoma remained strong, revenues of certain retina products were below expectations ."demand for company's new flagship Cyclo G6 laser platform for glaucoma remained strong".  Full Article

Iridex sees Q3 revenue $11 million to $11.3 million
Thursday, 4 Aug 2016 04:05pm EDT 

Iridex Corp : Q2 loss per share $0.03 . Q2 revenue rose 32 percent to $11.9 million . Month results . Sees Q3 2016 revenue $11 million to $11.3 million . Company continues to expect revenue growth for full year 2016 to be in low double-digits .Expect higher revenue in q4 relative to q3 due to typical seasonality.  Full Article

IRIDEX Corp gives Q1, FY 2016 revenue guidance
Thursday, 3 Mar 2016 04:05pm EST 

IRIDEX Corp:Expects revenue growth for FY 2016 to be in the low double-digits, with stronger growth in the second half of the year as the installed base of Cyclo G6 systems grows and drives an increase in revenues of the Company's disposable probes.Says for Q1 2016, anticipates revenues of $11.5 million to $11.8 million, which represents growth of 7 percent to 9 percent from the first quarter of 2015, and operating expenses to be $5.0 million to $5.3 million.  Full Article

Iridex Corp gives Q4 2015 revenue guidance
Thursday, 5 Nov 2015 04:05pm EST 

Iridex Corp:Anticipates Q4 2015 revenue of $11.5 million to $11.9 million.  Full Article

BRIEF-Iridex Q2 revenue falls 16 pct

* Iridex announces 2017 second quarter, six-month financial results